Overall, a high level of TIGIT+Foxp3+ γδ T cells is associated with poor OS of AML patients; thus, we will further confirm the function of these subsets and whether they could be a potential immune biomarker for adverse prognosis. This evidence concerns the gene FOXP3 and acute myeloid leukemia.